Published in Dev World Bioeth on May 01, 2005
Controlling healthcare-associated infections in the international research setting. J Acquir Immune Defic Syndr (2013) 0.81
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries. BMC Infect Dis (2016) 0.79
Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings. Dev World Bioeth (2013) 0.77
What drives health research in a developing country? Croat Med J (2007) 0.76
Developing the ethics of implementation research in health. Implement Sci (2016) 0.75
Is a national standard of care always the right one? Dev World Bioeth (2007) 0.75
Responsibilities to plan for ancillary care pose ethical challenges for nutrition research in the community setting. J Nutr (2012) 0.75
Public stem cell banks: considerations of justice in stem cell research and therapy. Hastings Cent Rep (2004) 2.53
Moving from research ethics review to research ethics systems in low-income and middle-income countries. Lancet (2009) 1.62
Ethical oversight of research in developing countries. IRB (2003) 1.14
Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention. Bioethics (2014) 0.82
Controlling healthcare-associated infections in the international research setting. J Acquir Immune Defic Syndr (2013) 0.81
Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa. Clin Trials (2011) 0.81
Should sponsors and DSMBs share interim results across trials? J Acquir Immune Defic Syndr (2011) 0.81
Adding insult to injury: reluctance to engage in clinical research with at-risk groups further disenfranchises these populations. Am J Bioeth (2009) 0.77
Ethical considerations in HIV prevention and vaccine research in resource-limited settings. J Acquir Immune Defic Syndr (2014) 0.75